Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66 155 cases and 91 307 controls

Lancet

Volumn 367, Issue 9511, 2006, Pages 651-658

  Ye, Zheng ^a   Liu, Eugene H C ^b   Higgins, Julian P T ^c   Keavney, Bernard D ^d   Lowe, Gordon D O ^e   Collins, Rory ^f   Danesh, John ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 7; GLYCOPROTEIN IB ALPHA; GLYCOPROTEIN IIIA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA ANALYSIS; DNA POLYMORPHISM; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

EID: 33344478392     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68263-9     Document Type: Article

References (38)

1. K Juul, A Tybjaerg-Hansen, P Schnohr, BG Nordestgaard Factor V Leiden and the risk for venous thromboembolism in the adult Danish population Ann Intern Med 140 2004 330 337
2. DA Lane, PJ Grant Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease Blood 95 2000 1517 1532
3. RE Simmonds, J Hermida, SM Rezende, DA Lane Haemostatic genetic risk factors in arterial thrombosis Thromb Haemost 86 2001 374 385
4. H Rasche Haemostasis and thrombosis: an overview Eur Heart J 3 suppl 2004 Q3 Q7
5. B Voetsch, J Loscalzo Genetic determinants of arterial thrombosis Arterioscler Thromb Vasc Biol 24 2004 216 229
6. MA El Hazmi Hematological risk factors for coronary heart disease Med Princ Pract 11 suppl 2 2002 56 62
7. A Manzoli, F Andreotti, AM Leone, G Sperti, P Zecchi, G Di Sciascio Vascular and haemostatic gene polymorphisms associated with non-fatal myocardial infarction: a critical review Ital Heart J 1 2000 184 193
8. RM Bertina, BP Koeleman, T Koster Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
9. M Hunault, AA Arbini, S Lopaciuk, JA Carew, KA Bauer The Arg353Gln polymorphism reduces the level of coagulation factor VII: in vivo and in vitro studies Arterioscler Thromb Vasc Biol 17 1997 2825 2829
10. SR Poort, FR Rosendaal, PH Reitsma, RM Bertina A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 1996 3698 3703
11. P Eriksson, B Kallin, FM van't Hooft, P Bavenholm, A Hamsten Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction Proc Natl Acad Sci USA 92 1995 1851 1855
12. TJ Kunicki, M Kritzik, DS Annis, DJ Nugent Hereditary variation in platelet integrin alpha 2 beta 1 density is associated with two silent polymorphisms in the alpha 2 gene coding sequence Blood 89 1997 1939 1943
13. V Afshar-Kharghan, CQ Li, M Khoshnevis-Asl, JA Lopez Kozak sequence polymorphism of the glycoprotein (GP) Ibalpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex Blood 94 1999 186 191
14. EJ Weiss, PF Bray, M Tayback A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis N Engl J Med 334 1996 1090 1094
15. L Iacoviello, F Burzotta, A Di Castelnuovo, F Zito, R Marchioli, MB Donati The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis Thromb Haemost 80 1998 1029 1030
16. AH Wu, GJ Tsongalis Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases Am J Cardiol 87 2001 1361 1366
17. K Juul, A Tybjaerg-Hansen, R Steffensen, S Kofoed, G Jensen, BG Nordestgaard Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses Blood 100 2002 3 10
18. S Doix, M Mahrousseh, M Jolak Factor V Leiden and myocardial infarction: a case, review of the literature with a meta-analysis Ann Cardiol Angeiol (Paris) 52 2003 143 149
19. RJ Kim, RC Becker Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies Am Heart J 146 2003 948 957
20. A Di Castelnuovo, G de Gaetano, MB Donati, L Iacoviello Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis Thromb Haemost 85 2001 626 633
21. SM Boekholdt, NR Bijsterveld, AH Moons, M Levi, HR Buller, RJ Peters Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review Circulation 104 2001 3063 3068
22. C Meisel, JA Lopez, K Stangl Role of platelet glycoprotein polymorphisms in cardiovascular diseases Naunyn Schmiedebergs Arch Pharmacol 369 2004 38 54
23. F Burzotta, K Paciaroni, S De G20210A prothrombin gene polymorphism and coronary ischaemic syndromes: a phenotype-specific meta-analysis of 12 034 subjects Heart 90 2004 82 86
24. K Middendorf, P Gohring, TY Huehns, D Seidel, G Steinbeck, S Nikol Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction Am Heart J 147 2004 897 904
25. MM Zhu, J Weedon, LT Clark Meta-analysis of the association of platelet glycoprotein IIIa PlA1/A2 polymorphism with myocardial infarction Am J Cardiol 86 2000 1000 1005
26. D Burr, H Doss, GE Cooke, PJ Goldschmidt-Clermont A meta-analysis of studies on the association of the platelet PIA polymorphism of glycoprotein IIIa and risk of coronary heart disease Stat Med 22 2003 1741 1760
27. GD Smith, R Harbord, J Milton, S Ebrahim, JAC Sterne Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies Arterioscler Thromb Vasc Biol 25 2005 2228 2233
28. JP Higgins, SG Thompson, JJ Deeks, DG Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
29. R DerSimonian, N Laird Meta-analysis in clinical trials Controlled Clin Trials 7 1986 177 188
30. DA Lane, H Philippou, JA Huntington Directing thrombin Blood 106 2005 2605 2612
31. DT Eitzman, RJ Westrick, Y Shen Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice Circulation 111 2005 1822 1825
32. GD Lowe Hormone replacement therapy and cardiovascular disease: increased risks of venous thromboembolism and stroke, and no protection from coronary heart disease J Intern Med 256 2004 361 374
33. S Greenland Invited commentary: a critical look at some popular meta-analytic methods Am J Epidemiol 140 1994 290 296
34. T Tsunoda, GM Lathrop, A Sekine Variation of gene-based SNPs and linkage disequilibrium patterns in the human genome Hum Mol Genet 13 2004 1623 1632
35. SR Lentz Another lesson from the factor V Leiden mouse: thrombin generation drives arterial disease Circulation 111 2005 1733 1734
36. B Keavney, C McKenzie, S Parish Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls Lancet 355 2000 434 442
37. HM Colhoun, PM McKeigue, GD Smith Problems of reporting genetic associations with complex outcomes Lancet 361 2003 865 872
38. JPA Ioannidis, TA Trikalinos, EE Ntzani, DG Contopoulos-Ioannidis Genetic associations in large versus small studies: an empirical assessment Lancet 361 2003 567 571